☰
Virogentics has launched clinical trials in the Democratic Republic of Congo, focusing on the HIV/AIDS treatment supervised by Neuro Pharma Ltd.
Virogentics 已在刚果民主共和国启动 HIV/AIDS 治疗的临床试验，由 Neuro Pharma Ltd 监督。
Preparations for clinical studies targeting type 2 diabetes are underway, with promising preliminary findings suggesting significant potential for ITV-1's applications.
针对 2 型糖尿病的临床研究正在筹备中，初步研究结果显示 ITV-1 应用具有巨大的潜力。